CONFERENCE SCOPE:
Nanotechnology in life sciences
INSTITUTION:
UnivERSIDAD Nacional de Cordoba, Argentine
TITLE:
Next-gen therapeutics: Engineering hybrid nanoplatforms for targeted and controlled cancer therapy
ABSTRACT:
Hybrid nanoplatforms have emerged as next-generation systems for the targeted delivery of anticancer therapeutics, offering enhanced efficacy, reduced side effects, and improved bioavailability. By integrating organic and inorganic components, these hybrid systems can be precisely engineered to respond to specific biological cues, enabling controlled drug release and multifunctional behavior.
This presentation will discuss the design and engineering of hybrid magnetic nanoparticles and lipid-based nanosystems functionalized with inorganic nanoparticles, emphasizing their structural characteristics, stimuli-responsive properties, and therapeutic applications. These advanced nanoplatforms represent a significant step toward more personalized, effective, and intelligent cancer treatments.
BIO:
Mónica C. García is an Adjunct Professor at the National University of Córdoba (UNC) and an Adjunct Researcher at CONICET, Argentina. She earned her Pharmacy degree and Ph.D. in Pharmaceutical Sciences from UNC, focusing on the design and evaluation of innovative drug delivery systems (DDS).
Dr. García has held several international research positions, including visiting appointments at the University of São Paulo (Brazil), Brown University (USA, Fulbright Award), Harvard University (USA, Fulbright Award), the University of Seville (Spain, AUIP Fellow), the Institute for Bioengineering of Catalonia (IBEC, Spain), Pompeu Fabra University (Erasmus+ Scholar), the University of Pavia (Italy, CICOPS Scholar), and the Universidad Nacional Mayor de San Marcos (Peru).
Her multidisciplinary collaborations with researchers in biochemistry, medicine, biology, and engineering have strengthened her expertise in the development of hybrid nanosystems for targeted drug delivery. She has authored peer-reviewed articles, book chapters, and a patent, and has presented her work at numerous international conferences.
Beyond research, Dr. García has extensive teaching experience and a strong commitment to science outreach and education. Her current research focuses on engineering hybrid nanoplatforms for controlled and targeted cancer therapy.